Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Impaired Cognition: later-stage trial registry
2 of 7 indexed Impaired Cognition trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Impaired Cognition: 7 US clinical trials tracked, 2 recruiting.
Impaired Cognition is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is FORUM Pharmaceuticals, running 2 of these trials.
Enrollment posture brief
Registry condition impaired-cognition
OPEN 2 | RECR 29% | LATE 4 | EARLY 0 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)
Impaired Cognition lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Impaired Cognition on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Impaired Cognition is recruiting below its size-band peers.
2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Impaired Cognition research.
FORUM Pharmaceuticals accounts for 2 of 7 trials (28.6%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Impaired Cognition enrolment sits around 438 participants.
Median target enrolment is 438 among the 7 trials that report a genuine target (sentinel values excluded). 1 of those (14.3%) plan for fewer than 100 participants.
-
Impaired Cognition research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
Massachusetts General Hospital
NCT02290834
Simultaneous Recumbent Cycling and Cognitive Training
University of Missouri, Kansas City
NCT04556227
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
FORUM Pharmaceuticals
NCT01716975
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
FORUM Pharmaceuticals
NCT01714661
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
Vanderbilt University Medical Center
NCT01211522
The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure
Vanderbilt University Medical Center
NCT01739933
The Impact of Family Financial Support on Cognition
University of California, Los Angeles
NCT02723318
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Impaired Cognition records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Impaired Cognition trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Impaired Cognition page
7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Impaired Cognition trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- FORUM Pharmaceuticals sponsors the most Impaired Cognition trials on record, review their full trial history before evaluating a specific study. See FORUM Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Impaired Cognition condition card totals 7 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.